These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 649993

  • 21. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL, Petersdorf RG.
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [Abstract] [Full Text] [Related]

  • 22. Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus.
    Rozenberg-Arska M, Fabius GT, Beens-Dekkers MA, Duursma SA, Sabath LD, Verhoef J.
    Chemotherapy; 1979 Mar; 25(6):352-5. PubMed ID: 260698
    [Abstract] [Full Text] [Related]

  • 23. Identification of cephalosporin-resistant Staphylococcus aureus with the disc diffusion method.
    Hallander HO, Laurell G.
    Antimicrob Agents Chemother; 1972 May; 1(5):422-6. PubMed ID: 4670484
    [Abstract] [Full Text] [Related]

  • 24. Influence of cephalosporin antibiotics on blood coagulation and platelet function.
    Natelson EA, Brown CH, Bradshaw MW, Alfrey CP, Williams TW.
    Antimicrob Agents Chemother; 1976 Jan; 9(1):91-3. PubMed ID: 1259395
    [Abstract] [Full Text] [Related]

  • 25. Temperature effect on cephalothin sensitivity of methicillin-resistant Staphylococcus aureus.
    Canawati HN, Sapico FL, Montgomerie JZ, Zucchero J.
    Am J Clin Pathol; 1981 Mar; 75(3):391-4. PubMed ID: 6908435
    [Abstract] [Full Text] [Related]

  • 26. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.
    Bran JL, Levison ME, Kaye D.
    Antimicrob Agents Chemother; 1972 Jan; 1(1):35-40. PubMed ID: 4596741
    [Abstract] [Full Text] [Related]

  • 27. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG, Midtvedt T, Dahl O.
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [Abstract] [Full Text] [Related]

  • 28. Activity of ten cephalosporins on biomass of methicillin-susceptible and -resistant Staphylococcus aureus.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F.
    Antimicrob Agents Chemother; 1980 May; 17(5):856-60. PubMed ID: 6901595
    [Abstract] [Full Text] [Related]

  • 29. A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation.
    Green ER, Subramanian S, Faden H, Quintiliani R, Nightingale CH.
    Ann Thorac Surg; 1981 Feb; 31(2):155-60. PubMed ID: 7458486
    [Abstract] [Full Text] [Related]

  • 30. Resistance of Staphylococcus aureus to semisynthetic penicillins and cephalothin.
    Richmond AS, Simberkoff MS, Schaefler S, Rahal JJ.
    J Infect Dis; 1977 Jan; 135(1):108-12. PubMed ID: 583903
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC, Ho SW.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [Abstract] [Full Text] [Related]

  • 32. Combination of bacteriostatic and bactericidal drugs: lack of significant in vitro antagonism between penicillin, cephalothin, and rolitetracycline.
    Daschner FD.
    Antimicrob Agents Chemother; 1976 Nov; 10(5):802-8. PubMed ID: 795370
    [Abstract] [Full Text] [Related]

  • 33. Comparative plasma bactericidal activity of cephapirin and cefazolin.
    Hottendorf GH, Price KE, Van Harken DR.
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):364-70. PubMed ID: 809250
    [No Abstract] [Full Text] [Related]

  • 34. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C, Libke RD, Engelking ER, Clarke JT, Kirby MM.
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [Abstract] [Full Text] [Related]

  • 35. Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.
    Barry AL, Thornsberry C, Jones RN, Fuchs PC, Gavan TL, Gerlach EH.
    Am J Clin Pathol; 1978 Dec; 70(6):909-13. PubMed ID: 727174
    [Abstract] [Full Text] [Related]

  • 36. Cephapirin therapy in infective endocarditis.
    Burch KH, Quinn EL, Saravolatz LD, Madhavan T, Jovanovich JF, Pohlod D.
    South Med J; 1983 Apr; 76(4):448-52. PubMed ID: 6836358
    [Abstract] [Full Text] [Related]

  • 37. The in vitro spectrum of the cephalosporins.
    Washington JA.
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [Abstract] [Full Text] [Related]

  • 38. In vitro and in vivo microbiological evaluation of Cephapirin, a new antibiotic.
    Renzini G, Ravagnan G, Oliva B.
    Chemotherapy; 1975 Apr; 21(5):289-96. PubMed ID: 1098870
    [Abstract] [Full Text] [Related]

  • 39. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A, Durosoir JL, Saliou P.
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [Abstract] [Full Text] [Related]

  • 40. Penetration of cephapirin and cephalothin into the right atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
    Quintiliani R, Klimek J, Nightingale CH.
    J Infect Dis; 1979 Mar; 139(3):348-52. PubMed ID: 312890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.